# Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase

> **NCT07640542** · EARLY_PHASE1 · RECRUITING · sponsor: **MODAG GmbH** · enrollment: 9 (estimated)

## Conditions studied

- Parkinson Disease (PD)
- MSA - Multiple System Atrophy
- Healthy Adult Participants

## Interventions

- **DRUG:** [11C]MODAG-005

## Key facts

- **NCT ID:** NCT07640542
- **Lead sponsor:** MODAG GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-29
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640542, "Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07640542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*